IL6 and plasma cell myeloma: Studies have shown that stromal cells in the microenvironment of myeloma may inhibit the expression of miRNA in myeloma cells by secreting high levels of IL-6, thereby inhibiting cell proliferation, reducing the sensitivity of myeloma cells to chemotherapeutic drugs, and participating in the occurrence of MM resistance [21–23].